LIM Domain 7 (LMO7) Peptid
LMO7
Reaktivität: Human
Wirt: Synthetic
BP, BI
Produktnummer ABIN5685242
Kurzübersicht für LIM Domain 7 (LMO7) Peptid (ABIN5685242)
Target
LMO7
(LIM Domain 7 (LMO7))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), BioImaging (BI)
-
-
Produktmerkmale
- LMO7 peptide corresponds to 12 amino acids of LMO7.
-
-
-
-
Applikationshinweise
- LMO7 Peptide is used for blocking the activity of LMO7 antibody . The LMO7 antibody ships at 0.5 mg/mL and the LMO7 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- LMO7 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
- LMO7 (LIM Domain 7 (LMO7))
-
Gen-ID
- 4008
-
OMIM
- 4929268
-
UniProt
- Q8WWI1
Target
-
Sie sind hier:
